|
|
|
|
|
|
by tim333
330 days ago
|
|
|
They've managed to treat sickle cell. >CRISPR/Cas9 can be directed to cut DNA in targeted areas, enabling the ability to accurately edit (remove, add, or replace) DNA where it was cut. The modified blood stem cells are transplanted back into the patient where they engraft (attach and multiply) within the bone marrow... https://www.fda.gov/news-events/press-announcements/fda-appr... |
|
|